Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.04
Conference call: SiTime Sees Q4 Adj EPS $4.76 vs $3.72 Est; Sees Sales $331.000M-$341.000M vs $315.191M Est
Benzinga
2026.11.04
Conference call: Aeva Technologies Affirms FY2026 Sales Guidance of $30.000M-$36.000M vs $32.355M Est
Benzinga
2026.11.04
Canaccord Genuity Maintains Buy on Travere Therapeutics, Raises Price Target to $72
Benzinga
2026.11.04
Canaccord Genuity Maintains Hold on Sprout Social, Raises Price Target to $13.5
Benzinga
2026.11.04
Canaccord Genuity Maintains Buy on Ultragenyx Pharmaceutical, Lowers Price Target to $34
Benzinga
2026.11.04
Compass Diversified Hldgs Q3 EPS $0.05 Beats $(0.34) Estimate, Sales $422.930M Beat $410.524M Estimate
Benzinga
2026.11.04
$100 Invested In Welltower 5 Years Ago Would Be Worth This Much Today
Benzinga
2026.11.04
Canaccord Genuity Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $633
Benzinga
2026.11.04
CORRECTION: ARM Holdings Sees Q3 Adj EPS $0.52-$0.60 vs $0.56 Est; Sees Sales $1.490B-$1.590B vs $1.528B Est
Benzinga
2026.11.04
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $32
Benzinga
2026.11.04
Canaccord Genuity Maintains Buy on Hillman Solutions, Lowers Price Target to $12
Benzinga
2026.11.04
CORRECTION: Host Hotels & Resorts Raises FY2026 FFO Guidance from $2.15-$2.18 to $2.21 vs $2.19 Est; Raises FY2026 Sales Guidance from $6.124B-$6.153B to $6.213B vs $6.133B Est
Benzinga
2026.11.04
Tom Lee Says Democratic Sweep Could Fuel 15% to 20% Tech Rally
BeInCrypto
2026.11.04
Canaccord Genuity Maintains Buy on Freshworks, Raises Price Target to $17
Benzinga
2026.11.04
Canaccord Genuity Maintains Buy on DigitalOcean Holdings, Lowers Price Target to $180
Benzinga
2026.11.04
Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $33
Benzinga
2026.11.04
UPDATE: McKesson Raises FY2027 Adj EPS Guidance from $44.20-$45.00 to $45.60-$46.40 vs $44.71 Est; Raises FY2027 Sales Guidance from $423.601B-$439.739B to $427.636B-$443.773B vs $432.063B Est
Benzinga
2026.11.04
Canaccord Genuity Maintains Buy on Beam Therapeutics, Lowers Price Target to $78
Benzinga
2026.11.04
Canaccord Genuity Maintains Buy on AtriCure, Raises Price Target to $67
Benzinga
2026.11.04
Fluor Receives Full Notice To Proceed For Sierra Gorda Copper Mine Expansion Project In Chile
Benzinga
2026.11.04
Canaccord Genuity Maintains Hold on Amgen, Raises Price Target to $440
Benzinga
2026.11.04
Here’s How Much You Would Have Made Owning NatWest Group Stock In The Last 5 Years
Benzinga
2026.11.04
Ascentage Pharma To Present Data On Four Innovative Drug Candidates At ASH 2026, Including First Clinical Results For APG-5918
Benzinga
2026.11.04
CORRECTION: Crane NXT Q3 Adj. EPS $1.28 Beats $1.21 Estimate, Sales $497.000M Beat $494.995M Estimate
Benzinga
2026.11.04
William Blair Downgrades Stevanato Group to Market Perform
Benzinga
2026.11.04
Morguard Q3 FFO $5.20 Up From $5.18 YoY, Sales $287.087M Up From $278.220M YoY
Benzinga
2026.11.04
UPDATE: Seneca Foods Q2 Adj. EPS $5.07 Beats $3.82 Estimate, Sales $492.590M Miss $506.000M Estimate
Benzinga
2026.11.04
UBS Maintains Neutral on Grupo Televisa, Lowers Price Target to $2.3
Benzinga
2026.11.04
UBS Maintains Neutral on Stevanato Group, Lowers Price Target to $16
Benzinga
2026.11.04
CORRECTION: MKS Sees Q4 Adj EPS $4.62-$5.38 vs $3.93 Est; Sees Sales $1.490B-$1.530B vs $1.398B Est
Benzinga
1
...
248
249
250
251
252
253
...
712
>